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Throughout the world, there are increasing demands for alternate approaches to advanced cancer 
therapeutics. Numerous potentially chemotherapeutic compounds are developed every year for 
clinical trial and some of them are considered as potential drug candidates. Nanotechnology-based 
approaches have accelerated the discovery process, but the key challenge still remains to develop 
therapeutically viable and physiologically safe materials suitable for cancer therapy. Here, we report 
a high turnover, on/off-switchable functionally popping reactive oxygen species (ROS) generator 
using a smart mesoporous titanium dioxide popcorn (TiO2 Pops) nanoarchitecture. The resulting TiO2 
Pops, unlike TiO2 nanoparticles (TiO2 NPs), are exceptionally biocompatible with normal cells. Under 
identical conditions, TiO2 Pops show very high photocatalytic activity compared to TiO2 NPs. Upon 
on/off-switchable photo activation, the TiO2 Pops can trigger the generation of high-turnover flash 
ROS and can deliver their potential anticancer effect by enhancing the intracellular ROS level until it 
crosses the threshold to open the ‘death gate’, thus reducing the survival of cancer cells by at least 
six times in comparison with TiO2 NPs without affecting the normal cells.
Over the past decade, significant effort has been expended1–3 to find new approaches for cancer therapy4–7. 
Compared with chemotherapeutic, surgical, radiological and other conventional therapies, photocatalytic 
and photodynamic treatments are considered promising alternative strategies for cancer treatment8–11. 
Nanoparticle-based systems have been intensively investigated in this regard and often emerged as poten-
tial key elements in a photocatalytic apparatus for such alternative anticancer therapy12,13. However, the 
integration of nanoscale systems into clinical settings has been greatly impeded by the inability to spe-
cifically target the tumour cells and by non-specific distribution and damage caused to normal cells14–16.
The most promising photocatalytic material is TiO2, following its FDA approval in 199617. It has been 
useful as a catalyst for photo-degradation of organic compounds and the deactivation of microorganisms. 
It has been reported that various ROS, such as superoxide (O2•−), singlet oxygen (1O2), hydroxyl radical 
(•OH), hydroperoxyl radical (HO2•), and hydrogen peroxide (H2O2), are generated on the TiO2 surface 
and react with organic or inorganic compounds in the gas and liquid phases. Altered redox status and the 
intrinsic high ROS level in cancer cells due to multiple genetic alterations and high oxidative stress, thus 
creates a unique opportunity to preferentially eliminate these cells by further induction of ROS insults 
to open up the ‘death gate’ and deliver the associated therapeutic benefits18,19.
Recent studies have shown that the geometry of nanoparticles can significantly modulate their 
photo-catalytic activity20. In addition, the photocatalytic activity of TiO2 crystals is heavily depend-
ent upon the nanoscale surface structure, including the surface atomic arrangement and coordination, 
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especially when the particle size is reduced to the nanometer scale, leading to a large specific surface 
area21. Based on the backgrounds, we have employed a new type of mesoporous TiO2 structure (i.e., 
TiO2 Pops) to explore the effects of nano-architecture on the control of intracellular ROS production. 
We present a comparative study of the photocatalytic activities of TiO2 NPs and Pops in order to clarify 
the underlying mechanism that regulates the photocatalysis of the nanostructures and to show how such 
nano-scale engineering switches the intracellular flash ROS in cancer and normal cells. The present 
communication reports on/off-switchable photon-triggered ROS production, its effect on cancer cells 
in vitro and the comparative biocompatibility of this novel nano-architecture with non-cancerous cells.
The precursor material was synthesised via a sol-gel method and scanning electron microscopy (SEM) 
images of the calcined mesoporous TiO2 Pops, prepared following the solvothermal process, showed 
controlled morphology and uniform monodisperse sub-micro particles22. The precursor beads had 
smooth surfaces without obvious granular features and a diameter of 600 ± 50 nm (Fig.  1a). After

 the 
solvothermal treatment, monodispersed TiO2 Pops with a diameter of 500 ± 50 nm and comparatively 
Figure 1. SEM images of mesoporous TiO2 Pops, (a) micro-particles before solvothermal treatment,  
(b) mesoporous Pops after solvothermal treatment. (c) TEM image of solvothermally engineered mesoporous 
TiO2 nano-crystalls. (d) Pops nanocrystals with lattice spacing of d = 0.17 nm corresponding to the (105) 
plane of anatase phase of TiO2 in HRTEM. (e) Comparative X-ray diffraction patterns of mesoporous TiO2 
Pops and NPs.
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rough surfaces with surface area up to 100 m2/g were produced (Fig. 1b). As illustrated by high magni-
fication SEM images of these TiO2 Pops, ~14 nm sized nanocrystals and pores can be observed over the 
surface (Extended Fig.  1). Mesoporous TiO2 Pops were examined using transmission electron micros-
copy (TEM) to determine their nanoarchitecture, shape and appearance. The morphology of the spher-
ical Pops showed an extensive rough surface composed of a self-organised TiO2 nanocrystals that are 
quite uniform in nature with an average size of 500 nm (Fig. 1c). The crystal facets determined through 
high-resolution TEM (HRTEM) analysis delineates the lattice fringes of individual nanocrystals with 
lattice spacing of d = 0.17 nm corresponding to the (105) plane of anatase phase of TiO2 (Fig. 1d). The 
X-ray diffraction(XRD) pattern of these TiO2 Pops showed well resolved diffraction peaks (Fig.  1e). 
The corresponding characteristic 2θ values at 25.00 and 27.50o of the diffraction peaks confirm that the 
TiO2 NPs indeed contain both anatase and rutile phase. TiO2 Pops illustrated the characteristic 2θ value 
at 25.00o of the anatase phase, which indicates that the TiO2 Pops consist of highly crystallised anatase 
without any impurity. The nature of the chemical bonds on both of the samples was analysed using 
high-energy resolution X-ray photoelectron spectroscopy (XPS). The XPS spectra of Ti 2p, O 1s were 
fitted into different components and the detailed high-energy resolution analysis is shown in extended 
Fig. 2. In the Ti 2p spectrum, spin-orbit split doublet Ti 2p3/2 and Ti 2p1/2 were found to only originate in 
both samples from the Ti4+ valence state (Ti 2p3/2 peak at 458.3 eV). The O 1 s spectra shown three dis-
tinct components: i) at 529.5 eV, originating from oxygen atoms in the TiO2 oxide lattice, ii) at 531.0 eV, 
probably related with OH bonds and ii) at 532.5 eV, probably related with H2O23.
The chemical photocatalytic activity of TiO2 NPs and Pops were compared and for the first time we 
showed a clear and distinct pattern with respect to catalyst amount, substrate concentration and photon 
exposure time (extended Fig.  3). We have engineered the TiO2 flash ROS generator for on-demand 
photodynamic anti-neoplastics therapy based on the following critical features and dynamicity of par-
ticle size, crystal phase and crystallinity on the reactivity. Firstly, the optimal ‘safe’ size is based on 
numerous examples drawn by Wiesner’s group, which showed clearly that 100 nm is the distinct cut-off 
size below which atypical surface reactivity arises and causes normal nanoscale toxicity24. Secondly, 
the anatase crystalinity is more prone to interact with the increase in complexity of the membrane 
and can create membrane leakage more effectively than the rutile form, but does not usually generate 
ROS25; whereas the rutile nanoforms generate ROS and induce general nanotoxicity. Based on these 
two critical features, we have engineered TiO2 Pops having a size greater than 100 nm to avoid normal 
nanotoxicity and to exploit the anatase phase of the Pops for comparatively selective binding to cancer 
cells for controlled inducible photodynamic therapy. The intracellular ROS level of prostate cancer cells 
(PC3) was triggered extensively by photon induced TiO2 Pops, but remained unaltered without photon 
excitation (Fig. 2a). In contrast, the nanoparticle form of the same material (i.e., TiO2 NPs) can induce 
oxidative stress without any photo induction and thus can induce unregulated cytotoxicity in normal 
embryonic fibroblast cells (MEF), as shown in right panel of Fig. 2a. Upon photoinduction the relative 
intracellular ROS level increased by 2.5 fold with respect to the untreated control (Fig. 2b). The effective 
switching of intracellular redox level of the entire population shows δ 1  δ 2, i.e., effective high-turnover 
induction of flash ROS for functionally popping the ‘off-state’ to ‘on-state’ for anti-neoplastic therapy 
with TiO2 pops. The intracellular occurence of such generated ROS is illustrated in Fig. 2c in normal, 
treated and induced conditions. The effect of the elevated ROS showed as the functional loss of mito-
chonrial activity.
One of the hallmarks of cancer cells is the presence of dysfunctional and hyperpolarised mitochon-
dria, and this facilitates cancer cell survival by perturbing the release of inter-mitochondrial membrane 
localised pro-apoptotic factors. The relative mitochondrial reductase activity estimated through a MTT 
assay using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide26, showed a reduction of both 
the mitochondrial function as well as the cell survival rate (Fig. 3a). The controlled manupulation of mito-
chondrial activity was further estimated in living cells using a Rosamine-based mitochondria-specific dye 
(MitoTracker Red CMXRos) and showed greater membrane potential-dependent accumulation under 
control conditions. This implies the depolarisation of the membrane potential when the system was 
turned from the ‘off-‘ to the ‘on-‘ state (Fig.  3b). The simultaneous fate of the cancer cells was esti-
mated on the basis of changes that occur in the permeability of cell membranes during apoptosis, using 
PO-PRO (Fig.  3c). Relative simultaneous observations on the same cell population showed that there 
was a decrese in mirochondrial function and increase in apoptotic population (Fig. 3d). The intracellular 
space was simultaniously probed using DAPI, Mitotracker Red and DCF-Da to observe the dynamic 
features of mitochondrial activity with ROS production under live conditions. This clearly showed the 
trade-off between generating high turnover ROS in ‘on’ condition and the compromised mitochondrial 
function only in case of Pops (Fig. 3e).
Finally, we considered spatiotemporal control of the ‘on/off ’− induction procedure. The normal intra-
cellular ROS level can be greatly impaired by nanoparticles in an uncontrollable fashion because of their 
nanoscale toxicity, as clearly is shown in Figs 2 and 3. We compared an ‘on/off ’− state of the ROS in the 
presence and absence of photoinduction both in NPs and Pops (Fig. 4a,b). The relative changes were very 
low in the case of NPs (quantified in our previous set of experiments as δ 2). However, we successfully 
established on/off-switching of intracellular ROS generation with our synthesised nanoarchitecture in 
accordance with our observation as δ 1 in Fig. 2b. The geometrical exposure profile shows that without 
any laser we can precisely induce a phototherapeutic effect even over a stretch of 10 cells or around 
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200 μ m. We were able to control cellular ROS expression with a precision of around 100 μ m through a 
‘pin-hole’ exposure (Fig. 4c). We believe this can be reduced to cellular level through more precise design 
of the masks.
Figure 2. In vitro comparative intracellular ROS generation profile in cancer and normal cells. Both 
cancer (PC3) and normal cells were cultured upto 70% confluency and around 106 cells in their respective 
medium and then treated with Pops and NPs with 50 μ g/mL and incubated for 12 h. The cells were then 
washed and incubated with 5 μ M 2′ ,7′ -dichlorofluorescin diacetate (DCF-Da) in PBS for 30 min at 37 °C. 
The cells were photo induced as described in the supplementary section. The entire population was shifted 
to produce a high amount of ROS after TiO2 Pops-mediated photoinduction in the PC3 cells (a). Notably, 
only Pops did not induce any ROS in PC3 and normal MEF cells (right panel). In contrast, NPs can itself 
induced ROS without any photoinduction (lower panel). The ROS expression level of the relative population 
in presence and absence of photon (b). Significant changes observed in nanocrystalline architure compared 
to NPs (b). Intracellular ROS localisation and amount under control, treated and induced conditions (c).
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Conclusion
Personalised on demand loco-regional therapeutics are emerging as target selective elixir for aggressive 
diseases like cancer. The most recent thought in this direction is mechanism-based therapy due to 
plasticity, heterogeneity and clonal evolution in response to the selective pressure imposed by cyto-
toxic measure and chemotherapeutic agents in tumours. Thus a new paradigm is shifting towards 
Figure 3. Effect of TiO2 nanoarchitecture: Concentration dependent estimation of the % cell survival by 
measuring the functional activity of the mitochondrial dehydrogenase within the live cells in ‘on-state’ 
and ‘off-state’ photo indduction (a). Flow cytometric measurement of mitochondrial membrane potential 
(Mitotracker red) and simultaneous determination of the onset of apoptotic population (b–c). The inverse 
correlation of the mitochondrial membrane potential and apoptosis in on- state of the therapy (d). The 
intracellular localisation and the dynamics of mitochondrial function and ROS in presence and absence of 
photoinduction and compared between Pops and NPs (e) in PC3 cells.
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adjustments of treatment regimens by targeting the unusual metabolic flexibility of tumour cells. 
Reactive oxygen species (ROS) is one such important parameter that regulating redox homeostasis 
within normal cells and distinctly altered redox status is present in cancer cells. We have exploited 
this intracellular redox imbalance that provides a biochemical basis for developing novel therapeutic 
strategies by developing a switchable smart nanoarchitecture that can provide a flash ROS boost. The 
process is enough to cross the oxidative threshold to selectively kill the cancer cells. This novel ‘fighting 
fire with fire’ approach offers custom-fit attractive features for developing on/off-switchable functional 
hand-in-hand activity to design suitable protocols towards the advancement of next generation switch-
able therapeutics.
Figure 4. On/off-switchable anti-neoplastic therapeutics and precision. Comparative three dimensional 
densitometric ROS level in the off and on state for fluorescence microscopic images (inset, 10X) in the 
presence and absence of photoinduction for nanoparticle (left panel) and Pops (right panel) treated PC3  
cells (a). The simultaneous expression of ROS (y-axis) and mitochondrial activity (x-axis) in ‘on/off-state’  
(upper/lower panel) in normal (MEF, right panel), transformed (HEK, left panel) and cancer (PC3, middle 
panel) cells (b). The geometrical and spatial precision for loco-regional theraputic activation (c).
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Methods
Synthesis, characterisation and functional assay of TiO2 pops. The mesoporous function-
ally popping nanoarchitectural TiO2 microbreads were synthesised in two steps using the method 
proposed by Chen et al.22,27,28 Sol-gel procedure for the synthesis of precursor TiO2 sub-micron spheres: 
In brief, 28 mM hexadecylamine (HDA from 90% Aldrich), 220 mM DI-water and 0.4 mM KCl were 
dissolved in ethanol solvent. HDA was used as a structure directing agent and KCl to control the 
ionic strength in the solution for the synthesis of a smooth and monodispersed morphology. The 
reaction of the Ti precursor with the oxygen source was completed by adding titanium(IV) iso-
propoxide (Aldrich, 97%, 70 mM) under vigorous stirring at room temperature. The solution was 
left static for 18 h under a fume hood and then centrifuged and dried at room temperature. A solvo-
thermal method was used for surface treatment of the resulting TiO2 sub-micro particles. They were 
dispersed in a mixture of ethanol/DI-water (2:1, v/v) which contained 0.55 M ammonia solution 
(Merck, 25%). The solution was transferred into a teflon-lined autoclave and placed in a furnace for 
18 h at 170 °C. Finally, the suspension was centrifuged and the mesoporous particles were dried in 
air at room temperature.
The particle morphology was observed using a Hitachi S4700 field-emission scanning electron micro-
scope (SEM, Hitachi-S4160). Transmission electron microscopy (TEM) was performed using a Jeol JEM-
2100 operating at 200 kV to determine the overall shape and appearance of the mesoporous TiO2 Pops. 
High-resolution TEM (HRTEM) analysis was employed to determine the crystal facets. Lattice fringes of 
individual nanocrystals were imaged with HRTEM. The crystal structure properties of the TiO2 nanos-
tructures were obtained from hard X-ray low-angle reflectivity measurements, using a Philips PW1710 
powder diffractometer with a copper anode source (Cu Kα, lambda = 1.54 Å), operating at 0.8 kW and 
with an accuracy of 0.015° 2-theta. For surface chemistry charaterisation, X-ray photoelectron spec-
troscopy (XPS or ESCA) analyses were carried out on a PHI-TFA XPS spectrometer manufactured by 
Physical Electronics Inc. The analysed area was 0.4 mm in diameter and the depth was about 3–5 nm. 
Sample surfaces were excited by X-ray radiation from a monochromatic Al source at photon energy of 
1486.60 eV. The high-energy resolution spectra were acquired with an energy analyser operating at a 
resolution of about 0.60 eV and pass energy of 29 eV.
In order to study ROS generation, photocatalysis experiments were performed by adding 5 mg 
TiO2 particles to 5 mL ethanol, and the suspension was sonicated for ten min. Then, 1 × 10−3 g/L 
1,5-diphenylcarbazide (DPCI) was added to the suspension, and the mixture was stirred magnetically 
for fifteen min in the dark. The beaker containing the suspension was placed under a 4 W UV-handheld 
lamp and irradiated at 365 nm. The distance between the beaker and the light source was 5 cm, the reac-
tion temperature was maintained at 25 °C. After irradiation, carbon tetrachloride was added to solution 
for extraction of 1,5-diphenylcarbazone (DPCO). After the final extraction, UV/vis absorption spectra 
of the solutions were recorded.
On/off-switchable photocatalysis. For the photo- activation and switching to the on- state of the 
therapeutic procedure, we operated under GMP conditions using a Labino BigBeam light source enabled 
with LED technology for a smooth uniform beam (9 × 365 nm UV-A LED’s) and narrow spectra with a 
peak of 365 nm. The exposure is completely (100%) free from harmful UV-B and the diodes emit almost 
no other wavelength with an output power of 3.5 mw/cm2 at 38 cm, with beam diameter 250 mm. The 
dose was optimised to an exposure of 180 sec. The dose was non-toxic to the normal embryonic fibroblast 
cells (MEF). There was no production of ROS with this photon exposure.
Intracellular ROS estimation. Both cancer (PC3) and normal cells were cultured up to 70% conflu-
ency and around 106 cells in their respective medium and then treated with TiO2 Pops and NPs, with a 
final concentration of 50 μ g/mL, and incubated for 12 h. The cells were then washed and incubated with 
5 μ M 2′ ,7′ -dichlorofluorescin diacetate (DCF-Da) in PBS for 30 min at 37 °C. The cells were then photo 
induced as described in the supplementary section. The entire population was shifted to produce high 
amount of ROS after TiO2 Pops mediated photoinduction in PC3 cells.
Flow cytometric measurement of mitochondrial activity and apoptosis. Cells plated and 
treated as mentioned for ROS estimation were then stained with 100 nM Mitotracker Red CMXROS 
(Life Technologies Inc.) for 45 min before trypsinisation. After collecting the trypsinised and resus-
pended cells in the medium the cells were centrifuged for 5 min at 300 g, washed with PBS and resus-
pended in 500 μ L of PBS and incubated with Po-Pro dye (Life Technologies Inc.) for 30 min on ice as 
per the manufacturer’s instructions29. The cells were then subjected to flow cytometry using FL4 and 
FL9 filters for Mitotracker Red and Po-Pro respectively (Gallios) and analysed using FlowJo software 
(vX.0.7).
Confocal microscopy. The cells treated or untreated as mentioned were fixed using 4% paraformal-
dehyde and imaged using Zeiss LSC microscopy as described previously in detail29.
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